SCHEMBL28005664

SCHEMBL28005664

CCNC(=O)c1cc(-c2ccccc2)cc(OC(C)=O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFD P00746 1/20 0.41
▸ HPGD P15428 4/20 0.40
▸ BRD4 O60885 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ ITGB3 P05106 1/20 0.40
▸ ITGA2B P08514 1/20 0.40
▸ HMGB1 P09429 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ GGT1 P19440 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ NAPRT Q6XQN6 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28005665 0.76 PTGS1 (0.59) HPGDBRD4NPC1ALDH1A1RAB9A
SCHEMBL1799221 0.76 PTGS2 (0.59) HPGDALDH1A1KDM4EESR1ITGB3
SCHEMBL28796445 0.74 BACE1 (0.42) CFDHPGDALDH1A1KDM4EESR1
SCHEMBL12391548 0.74 PTGER4 (0.47) HPGDNPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL27769325 0.74 TDP1 (0.44) CFDHPGDALDH1A1KDM4EESR1
SCHEMBL27769336 0.74 TDP1 (0.44) CFDHPGDALDH1A1KDM4EESR1
SCHEMBL27748175 0.73 HDAC1 (0.52) HPGDBRD4ALDH1A1KDM4EESR1
SCHEMBL28794193 0.73 HDAC1 (0.41) CFDHPGDALDH1A1KDM4EESR1
SCHEMBL13626646 0.71 TACR3 (0.59) HPGDBRD4NPC1ALDH1A1SMN1; SMN2
SCHEMBL13626334 0.71 ACMSD (0.60) NPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103214464-B Tetrazole-substituted arylamides and application of tetrazole-substituted arylamides using as p2x3 and p2x2/3 receptor antagonists HOFFMANN LA ROCHE 2015-02-18 — — CN disclosed
Send feedback